Literature DB >> 31704277

Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.

Maria E Sheean1, Eva Malikova2, Dinah Duarte3, Giuseppe Capovilla4, Laura Fregonese5, Matthias P Hofer5, Armando Magrelli6, Segundo Mariz5, Fernando Mendez-Hermida7, Robert Nistico8, Tim Leest9, Nikolaos V Sipsas10, Stelios Tsigkos5, Dinko Vitezic11, Kristina Larsson5, Bruno Sepodes12, Violeta Stoyanova-Beninska13.   

Abstract

This review provides an overview of nonclinical in vivo models that can be used to support orphan designation in selected rare infectious diseases in Europe, with the aim to inform and stimulate the planning of nonclinical development in this area of often neglected diseases.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31704277     DOI: 10.1016/j.drudis.2019.10.015

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  1 in total

Review 1.  Regulatory Standards in Orphan Medicinal Product Designation in the EU.

Authors:  Stelios Tsigkos; Segundo Mariz; Maria Elzbieta Sheean; Kristina Larsson; Armando Magrelli; Violeta Stoyanova-Beninska
Journal:  Front Med (Lausanne)       Date:  2021-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.